Waters: New Growth Cycle in Laboratory Instruments Meets AI Biotechnology
Reading Time: 3 minutes
Waters benefits from the broader recovery in instruments. Organic growth is back in the high single-digit range. The acquisition of BD Biosciences and Diagnostic Solutions expands Waters in diagnostics and single-cell analyses, increasing recurring revenues. AI, pharma reshoring, and a multi-year replacement cycle are creating additional growth drivers. Waters (WAT) is a leading provider of analytical instruments, consumables, and software for pharmaceutical, biotech, research, and industrial laboratories. Core technologies include chromatography...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
